Cytokinetics (CYTK) Former CEO James Sabry Retires from Board

March 16, 2010 4:32 PM EDT Send to a Friend
Cytokinetics, Incorporated (NASDAQ: CYTK) announced the resignation of James H. Sabry, M.D., Ph.D., Co-founder and former Chief Executive Officer, from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login